Riassunto: STEMCELL Technologies annuncia la classificazione De Novo dell'FDA per il suo EasySep™ CD138 Positive Selection Kit a supporto dei test diagnostici oncologici

View Full Size

Download

Full Size JPEG, 1500x317, 111.1 KB
Small JPEG, 480x101, 44.6 KB
Preview JPEG, 144x30, 22.8 KB
Thumbnail JPEG, 120x25, 21.4 KB

Smart Multimedia Gallery

STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit is now classified by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment. (Photo: Business Wire)